Lacktman, Ferrante Featured in mHealthIntelligence about Telestroke Services

14 February 2018 mHealthIntelligence News
Partner Nate Lacktman and Senior Counsel Thomas Ferrante were quoted in an mHealthIntelligence article, “FDA OKs mHealth App That Uses AI to Spot Strokes, Alert Specialists,” about what the Bipartisan Budget Act of 2018’s elimination of originating-site restrictions for telestroke services will mean for health care systems and institutions with established stroke programs.

The FDA recently approved an mHealth application, Viz.AI, which uses artificial intelligence software to analyze CT scans for signs of a stroke, then sends a message to a neurologist. It contains specially-designed mobile units that can start treatment when transmitted to the patient’s location, and telestroke platforms that allow health care providers to reach neurologists who are based anywhere.

In conjunction with this news, mHealthIntelligence featured Lacktman and Ferrante’s comments from the telestroke section of their recent Health Care Law Today blog post, which analyzes the new federal funding bill: “Allowing more qualified originating sites, such as the patient’s home, ambulances and mobile stroke units, will provide broader options for health care systems that do not have constant access to a neurologist and allow institutions with established stroke programs opportunities for destination medicine and new patients.”

Related Services

Insights

State of Michigan Election, COVID-19, and Budget Update
22 October 2020
2020 Election Resource Center
AI Podcast Series, Episode 1: Setting the Stage with Technology Risk Expert Ken DeJarnette – Part One
21 October 2020
Privacy, Cybersecurity & Technology Law Perspectives
ERISA/Cybersecurity Considerations in the COVID Age
21 October 2020
Privacy, Cybersecurity & Technology Law Perspectives
A Review of Recent Whistleblower Developments
21 October 2020
Legal News: Whistleblower Developments